Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

14.98 +2.63 (+21.30%)

Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

March 01, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Ginkgo Bioworks Holdings's Earnings: A Preview ↗

February 28, 2023

Via Benzinga

Cronos Group Reports 2022 Fourth Quarter and Full-Year Results

February 28, 2023

From Cronos Group Inc.

Via GlobeNewswire

To The Moon: Intuitive Machines Blasts 10x in a Week...But Why?

February 28, 2023

The modern version of the Cold War Space Race has implications for scientific discovery and satellite communications. Intuitive Machines is in the thick of it.

Via MarketBeat

Is It Too Early to Invest in Ginkgo Bioworks? ↗

February 22, 2023

Ginkgo is on track to easily beat its guidance for 2022. But what about its bottom line?

Via The Motley Fool

Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock ↗

November 18, 2022

Ginkgo Bioworks has tumbled this week, but Cathie Wood is among the key buyers of DNA stock, picking up shares yesterday.

Via InvestorPlace

This Biotech Is Already Using AI, but Is the Growth Stock a Buy? ↗

February 24, 2023

Few biotechs can claim to be using AI in as central of a role as Ginkgo Bioworks.

Via The Motley Fool

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ginkgo Bioworks Holdings Inc. (DNA) Investigation

February 21, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

2 Bruised Growth Stocks to Buy While They're Cheap ↗

February 21, 2023

Both are on the verge of fast growth, and they haven't had any major setbacks yet.

Via The Motley Fool

The Next Big Disruptors? 3 Biotech Stocks Making Headlines. ↗

February 17, 2023

Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023.

Via InvestorPlace

3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street ↗

February 07, 2023

These stocks are risky. But they just might deliver huge gains if analysts are right.

Via The Motley Fool

Investigation Announced for Investors Who Lost Money with NYSE: DNA Shares over Possible Violations of Securities Laws by Ginkgo Bioworks Holdings, Inc. ↗

February 01, 2023

San Diego, CA -- (SBWIRE) -- 02/01/2023 -- An investigation was announced for investors of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares over potential securities laws violations by Ginkgo Bioworks...

Via SBWire

GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

January 27, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

3 Penny Stocks That Could Rise 500% in 2023 ↗

January 13, 2023

Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

January 04, 2023

On Wednesday, 35 companies reached new 52-week lows.

Via Benzinga

What You Missed On Wall Street On Friday ↗

December 31, 2022

In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold.

Via Talk Markets

Three Pharma Stocks to Sell Before They Die ↗

December 24, 2022

As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January.

Via InvestorPlace

Down 76% This Year, Is This Growth Stock Now a Screaming Buy? ↗

December 06, 2022

The company's strategy will take time to implement, but it'll make investors a lot richer if it works.

Via The Motley Fool

Analyzing Ginkgo Bioworks Holdings's Short Interest ↗

December 05, 2022

Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 7.31% since its last report. The company recently reported that it has 134.22 million shares sold short, which is 14.71% of all...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 ↗

November 29, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 30, 2022

During Wednesday's session, 107 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 28, 2022

On Monday, 79 companies reached new 52-week lows.

Via Benzinga

2 Biotech Stocks You Can Buy and Hold for the Next Decade ↗

November 28, 2022

These two companies are facing short-term issues that are likely to give way to long-term success.

Via The Motley Fool

Looking Into Ginkgo Bioworks Holdings's Recent Short Interest ↗

November 17, 2022

Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has fallen 14.12% since its last report. The company recently reported that it has 134.22 million shares sold short, which is 15.87% of all...

Via Benzinga

BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday ↗

November 17, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Target, Holley, Ferroglobe And Other Big Losers From Wednesday ↗

November 17, 2022

U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Ginkgo Bioworks Stock Is Sliding Wednesday Morning ↗

November 16, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower by 8.63% to $2.44 Wednesday morning. The company during Tuesday's after-hours session announced a public offering of Class A common...

Via Benzinga

Carnival, Ginkgo Bioworks And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

November 16, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Ginkgo Bioworks Stock Is Down After Hours: What's Happening? ↗

November 15, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Tuesday's after-hours session after the company announced a proposed public offering.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.